Showing posts with label paper. Show all posts
Showing posts with label paper. Show all posts

Friday 13 January 2017

Teenagers Diagnosed With Attention Deficit Hyperactivity Disorder

Teenagers Diagnosed With Attention Deficit Hyperactivity Disorder.
Some clan demand it "brain doping" or "meducation". Others label the problem "neuroenhancement". Whatever the term, the American Academy of Neurology has published a outlook paper criticizing the practice of prescribing "study drugs" to assistance memory and thinking abilities in healthy children and teens. The authors said physicians are prescribing drugs that are typically Euphemistic pre-owned for children and teenagers diagnosed with attention-deficit/hyperactivity jumble (ADHD) for students solely to improve their ability to ace a critical exam - such as the college acknowledging SAT - or to get better grades in school.

Dr William Graf, lead founder of the paper and a professor of pediatrics and neurology at Yale School of Medicine, emphasized that the statement doesn't suit to the appropriate diagnosis and treatment of ADHD. Rather, he is concerned about what he calls "neuroenhancement in the classroom". The incorrigible is similar to that caused by performance-boosting drugs that have been used in sports by such athletic luminaries as Lance Armstrong and Mark McGwire.

So "One is about enhancing muscles and the other is about enhancing brains". In children and teens, the use of drugs to correct collegiate performance raises issues including the possible long-term effect of medications on the developing brain, the distinction between normal and abnormal intellectual development, the confusion of whether it is ethical for parents to force their children to take drugs just to improve their academic performance, and the risks of overmedication and chemical dependency.

The lickety-split rising numbers of children and teens taking ADHD drugs calls acclaim to the problem. "The number of physician office visits for ADHD directorship and the number of prescriptions for stimulants and psychotropic medications for children and adolescents has increased 10-fold in the US over the carry on 20 years," he pointed out.